Sign in
4

Changes in Ownership

HAEMONETICS CORP Filed Acc 0001127602-20-017282

President & CEO sold 1,008 shares at $100.44 ($101,244)

  • President & CEO acquired 14,510 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Simon, Christopher · President & CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-05-15 Sale : show line 1 in the form −1,008 $100.44 $101,244 303,757 D
2020-05-18 Grant or award : show line 2 in the form +14,510 318,267 D
Open-market sales · 1,008 sh · avg $100.44 · $101,244

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-05-18 Grant or award : show line 3 in the form Non-qualified Stock Option (Right to Buy) +49,105 49,105 D
Loading xslF345X03/form4.xml…